Purpose: To determine the in vitro accuracy, test-retest repeatability, and interplatform reproducibility of T 1 quantification protocols used for dynamic contrast-enhanced MRI at 1.5 and 3 T. Methods: A T 1 phantom with 14 samples was imaged at eight centers with a common inversion-recovery spin-echo (IR-SE) protocol and a variable flip angle (VFA) protocol using seven flip angles, as well as site-specific protocols (VFA with different flip angles, variable repetition time, proton density, and LookLocker inversion recovery). Factors influencing the accuracy (deviation from reference NMR T 1 measurements) and repeatability were assessed using general linear mixed models. Interplatform reproducibility was assessed using coefficients of variation. Results: For the common IR-SE protocol, accuracy (median error across platforms ¼ 1.4-5.5%) was influenced predominantly by T 1 sample (P < 10 À6 ), whereas test-retest repeatability (median error ¼ 0.2-8.3%) was influenced by the scanner (P < 10 À6
INTRODUCTION
Dynamic contrast-enhanced MRI (DCE-MRI) is often used to quantify flow and permeability in various tumors (1) (2) (3) and organs (brain, breast, liver, kidney, prostate) (4) (5) (6) (7) (8) (9) (10) . Dynamic contrast-enhanced MRI captures the signal change in time with the intravenous injection of a gadolinium-based contrast agent by acquiring T 1 -weighted images before, during, and after injection of contrast agent at a high temporal resolution. The signaltime curves are usually converted to gadolinium concentration-time curves (5) , reflecting the contrast agent uptake and washout of the tissue of interest. Pharmacokinetic modeling (11) (12) (13) can then be applied to the concentration-time curves to determine tissue biological parameters such as intravascular-extravascular transfer rate constant for the contrast agent, K trans , and extravascular and extracellular volume fraction, v e . The precision of pharmacokinetic parameters is highly dependent on the conversion of T 1 -weighted signal to gadolinium concentration, and thus on the precontrast (native) T 1 value of the tissue of interest (8, 14) .
A simple approach is to assign a published T 1 value to the tissue of interest (15) (16) (17) . However, because literature-derived T 1 values are often based on studies in healthy volunteers (18) , this approach does not account for changes in tissue T 1 that occur with age (8) or disease (19, 20) . Further limitations of using a constant, literature-based baseline T 1 are that it does not account for interpatient variability and cellular heterogeneity in the tissue of interest (11, 19, 20) . The need for patient and tissue-specific DCE-MRI parameters motivates the effort to develop accurate, widely available precontrast T 1 measurements.
The longitudinal relaxation time T 1 can be measured by a variety of methods (21, 22) . The multiple-delay inversion-recovery (IR) method that originated from historical NMR experiments (23, 24) is considered the reference standard, but has limited spatial coverage and long acquisition times, which makes it impractical in clinical settings. The Look-Locker modified IR method (25) (26) (27) decreases the acquisition time by sampling the signal recovery curve multiple times per repetition time (TR) after application of several low flip-angle pulses during the acquisition. Despite shortened acquisition time, Look-Locker IR methods are still limited in spatial coverage. Another method that shares some of the same limitations as the IR method but with shorter overall scan times is the variable TR (VTR) method, in which T 1 -weighted signal is acquired with multiple TR values (8) . A frequently used alternative approach is to vary the radiofrequency tip angle while keeping the TR constant in a 3D spoiled gradient-echo acquisition, as in variable flip angle (VFA) methods (8, 22, 28, 29) . Variable flip angle measurements allow for voxel-based baseline (pre-DCE-MRI) T 1 mapping with the same spatial resolution and coverage as the DCE-MRI scan in a short amount of time. Similarly time-efficient, although less popular, is the proton density (PD) approach (30) , in which T 1 is derived by comparing PD-weighted images with DCE baseline (precontrast) images.
Previous publications have reported interscanner and intersite variability in the T 1 values measured with different methods (31, 32) , including the IR method (22) . In the brain, the Look-Locker modified IR method was found to consistently underestimate, and the VFA method to consistently overestimate, T 1 values in the white matter (22) . The accuracy and test-retest repeatability of measured T 1 values are influenced by the same factors that affect the generation and acquisition of MR signal, such as temperature in the magnet bore (32) , incomplete spoiling of transverse magnetization (33) and B 1 field inhomogeneity (8, 22) , the choice of the optimal sequence, and sequence parameters for the range of T 1 values to be measured. Additional factors contributing to variability include postprocessing, such as signal scaling by the image processing software (34) and the assumptions for the fitting function (22) .
This study seeks to identify and systematically investigate some of the sources of variability in the T 1 measurement process using a dedicated phantom in a multicenter setting. The described research was conducted by the Data Acquisition Working Group of the National Cancer Institute-sponsored Quantitative Imaging Network (35, 36) , whose purpose is to improve the repeatability and reproducibility of quantitative imaging, and promote its adoption as an evaluation tool in oncology clinical trials.
The purpose of our study was to determine the (i) accuracy (with respect to reference standard NMR T 1 values) of T 1 measurements obtained with two predefined T 1 measurement protocols common among participating sites, and with the specific T 1 measurement protocol(s) used at each participating site for DCE-MRI studies; (ii) test-retest repeatability of T 1 measurements obtained with the common and site-specific T 1 measurement protocol(s); and (iii) Interplatform reproducibility of the common T 1 mapping protocols at 1.5 and 3 T.
METHODS
A preliminary survey identified eight Quantitative Imaging Network sites that measured the baseline-tissue T 1 for DCE-MRI quantification, rather than using a fixed T 1 based on the literature. The DCE-MRI with T 1 measurement is performed at 1.5 T (two sites, two scanners) and 3 T (seven sites, eight scanners), for different organs or neoplasms ( Table 1) . The methods and protocols used for T 1 measurement varied among sites, with VFA methods being the most common (Table 1) because of the achievable extensive spatial coverage in a short amount of time.
National Institute of Standards and Technology T 1 Phantom and NMR Reference T 1 Measurement
To assess accuracy, repeatability and reproducibility of T 1 measurements among platforms, sequences, and protocols, we used a phantom containing the T 1 elements (Fig. 1 ) from the National Institute of Standards and Technology (NIST) system phantom (31, 32, 37) . The phantom consists of a 192-mm outer-diameter polycarbonate sphere filled with deionized water, containing a plastic plate with positioning markers and T 1 solution array. The T 1 array consists of 14 polycarbonate spheres (15-mm inner diameter, 20-mm outer diameter each), with 10 spherical samples equally spaced on a 50-mm diameter circle, and four inside the circle on a 40-mm grid. The anatomical directions on the central plate facilitate positioning of the phantom at scanner isocenter, with the central plate parallel to the coronal plane of the scanner. T 1 values in the range of 20 to 2000 ms were obtained by doping deionized water with NiCl 2 . The NiCl 2 concentrations of the solutions used to create the samples were determined by traceable inductively coupled plasma mass spectrometry measurements. The solutions are well-characterized and monitored by NIST for stability and accuracy (37) .
The NMR spectroscopy reference measurements were performed at 1.5 and 3 T by NIST investigators. Aliquots of each of the 14 NiCl 2 solutions were sealed into 2-mm outer-diameter quartz NMR tubes, which were then flame-sealed using a methane/oxygen torch. A fiber-optic temperature probe was positioned with the sensor in the middle of the radiofrequency coil. Each sample was equilibrated to 293.15 K (20 C) for a minimum of 15 min. Samples were shimmed using the Berger-Braun shimming method before collecting NMR-IR relaxation-time data (24) .
Image Acquisition
The Working Group developed a uniform T 1 phantom imaging protocol in collaboration with NIST. The T 1 phantom, along with a digital thermometer and scanning instructions, was shipped to the eight Quantitative Imaging Network centers, where it was scanned in duplicate (test-retest) sessions. The phantom was placed in the scanner room 8 h before scanning, to allow its temperature to stabilize. Temperature was measured in the bulk water of the phantom at the start and end of each experiment, with the provided digital thermometer. Sites were instructed to image the phantom using the same receive coils (head or body array) used for their DCE-MRI studies. Sites (5 and 8) performing breast DCE-MRI studies used head coils, as the phantom was too large to fit into breast coils. The phantom was positioned with the aid of a level to ensure that the T 1 array plate was aligned with the principal scanner directions (superior-inferior, anterior-posterior), and that the central NIST marker was located at scanner isocenter.
The phantom was scanned on 10 different platforms (Table 1) at two field strengths (two at 1.5 T and eight at 3 T) from three major vendors (Siemens Healthineers (Erlangen, Germany), GE Healthcare (Waukesha, WI), and Philips Healthcare (Best, the Netherlands)). All sites collected data with a common inversion-recovery spinecho (IR-SE) protocol and a common VFA protocol with seven flip angles. Both protocols were optimized to measure the full T 1 range of the NIST phantom (20-2000 ms) . A VFA sequence was chosen to build a common scanning protocol, as the VFA method was used by most sites (Table 1) for T 1 quantification in DCE-MRI. The scanning parameters of the common protocols, matched closely among the platforms, are summarized in Table 2 .
Additionally, seven of the eight sites collected data using the site-specific T 1 measurement protocols. The organs of interest for DCE-MRI studies, the T 1 mapping method, and scanner(s) on which the data were acquired at each site are summarized in Table 1 . The 14 site- Table S3 ).
specific T 1 measurement protocols, their associated acquisition parameters, as well as the range of T 1 values they were optimized to measure, are summarized in order of scanner number in Supporting Tables S1 and  S2 . Briefly, site-specific protocols included four methods: (i) VFA (nine protocols: protocols 2 and 3 for brain; 4b and 9b for liver; 4c, 9c, and 9d for prostate; and 8 and 10 for breast), (ii) VTR (two protocols: protocol 1 for prostate; 6 for brain); (iii) Look-Locker modified IR (two protocols: 4a and 9a for liver); and (iv) PD (one protocol: protocol 5 for soft-tissue sarcoma). The site-specific VFA protocols had 2 to 10 flip angles, and choice of flip angles was optimized for the anatomical application.
Image Analysis
Centralized data analysis was performed at one site (Icahn School of Medicine at Mount Sinai, New York, NY). The acquired T 1 data were uploaded by participating sites in DICOM format. Data were analyzed by a single observer (O.B., a physicist with 4 years of postdoctoral experience in image analysis), who placed circular regions of interest (average size 1.0 cm 2 ) in a central slice of each sphere using OsiriX Lite (version 8.0.2, Pixmeo SARL, Bernex, Switzerland). For Philips scanners, the signal intensity (SI) values (arbitrary units) were modified by scaling factors and stored in "private" DICOM fields by the vendor (38), converted to floating point values (34) , and then used for calculations. The mean region-of-interest SI was fitted according to the signal equation for each sequence (Supporting Information Eqs.
[1]- [5] ) to obtain T 1 values, using custom routines written in MATLAB R2015 (The MathWorks, Natick, MA).
Statistical Analysis
Statistical analysis was performed using MATLAB R2015 and SAS 9.4 (SAS Institute, Cary, NC). Statistical significance was defined as P < 0.05. Agreement of IR-SE T 1 measurements with reference NMR T 1 measurements was tested by Lin's concordance correlation coefficient (39, 40) and Bland-Altman statistics.
Accuracy was assessed with respect to NMR T 1 values as the reference. The accuracy error was computed as the percentage difference between T 1 measured with the common or site-specific protocols during the first (test) scanning session, and reference NMR T 1 (Eq. [1] ). Smaller values represent higher accuracy.
Accuracy Error ð%Þ ¼ 100 Á jT 1 protocol À T 1 NMR j=T 1 NMR [1] Test-retest repeatability was assessed by the precision error, calculated as the percentage difference of T 1 values measured in duplicate relative to the mean of the two measured values (Eq. [2] ). Smaller values represent higher repeatability.
Precision Error ð%Þ ¼
A general linear mixed model was used to compare the accuracy and precision errors of T 1 measurements across samples, field strengths, scanners, vendors, methods, and protocols (26) . The effects of sample (solution), field, scanner (individual platform), and vendor on the accuracy and precision errors of the common IR-SE and VFA protocol were tested separately and in combination. For site-specific protocols data, the acquisition protocol and measurement method were tested as additional predictive variables. The "protocol" variable represented each site-specific combination of sequence implementation and acquisition parameters (14 site-specific protocols listed in Supporting Tables S1 and S2), whereas the "method" variable encoded each of the four T 1 measurement methods (VFA, Look-Locker modified IR, VTR, and PD) used to generate data submitted by the sites. A stepwise model selection procedure was performed (41, 42) to identify the best subset of one or more independent, uncorrelated predictors of accuracy or precision. Model results were reported as least-square means 6 standard error, with smaller numbers representing better accuracy or precision. Comparisons of accuracy and precision errors were performed among the following factors: samples, field strengths, scanners, vendors, protocols (in the case of site-specific protocols for different anatomical applications), and methods (for sitespecific protocol data). Type 3 P values were reported for the general linear mixed model (43) , and Tukey adjusted P values (44) were reported for comparisons between factors.
Interplatform reproducibility for the T 1 measured in each sample with the common IR-SE and VFA protocols was assessed by intraclass correlation coefficient (ICC) and coefficient of variation (% CV ¼ 100 x standard deviation/mean calculated between platforms, for each reference T 1 value). Paired sample Wilcoxon signed-rank tests were used to compare CVs between field strengths and common protocols.
RESULTS
T 1 measurements were obtained on 10 scanners at two field strengths (1.5 T: two scanners; 3 T: eight scanners), 45 13 in duplicate sessions, with two common protocols and 14 site-specific protocols. All sites were able to implement the common protocols, with two minor exceptions (lowest TI ¼ 50 ms for the common IR-SE on the GE scanners 1 and 10, instead of 24 ms, and FA ¼ 19 instead of 20 for the common VFA protocol at site 4, on scanner 5, a Siemens Trio machine). Fourteen phantom samples were analyzed for the scans with the common protocols, totaling 560 (14 Â 10 Â 2 Â 2) T 1 measurements. Only the samples with T 1 values within the measurement range for which the site-specific protocols were optimized (8, 19, 20, 28, 30, 45) . T 1 ranges for each anatomical application, given in Supporting Tables S1  and S2 , were analyzed, totaling 112 (56 Â 2) T 1 measurements with the site-specific protocols. Goodness of fit was assessed by the coefficient of determination (R 2 ), which ranged between 0.85 and 0.99 for T 1 measurement with the common IR-SE protocol, between 0.88 and 0.99 for measurements with the common VFA protocol, and between 0.82 and 0.99 for measurements with sitespecific protocols. Typical fit plots for the common protocols are shown in Supporting Figures S2 and S3.
Temperature measurements in the bulk water of the phantom ranged between 18.5 and 22.6 C at the start (mean 20.8 6 1.15 C), and between 19.6 and 22.7 C at the end (mean 21.3 6 1.1 C) of experiments, with a temperature change observed between the start and end of experiments of 0.4 6 0.4 C.
Comparison of IR-SE and NMR Reference Measurements
The NMR reference measurements are listed in Supporting  Table S3 for each solution sample. There was excellent concordance between IR-SE and NMR measurements (concordance correlation coefficient > 0.99; P < 10
À6
), with some deviations from unity line observed at T 1 ¼ 500 ms and T 1 > 1500 ms (Fig. 2a) . Bland-Altman plots for all scanners (Fig. 2b) show near-zero bias, limits of agreement (230%, 30%), and highlight discrepancies between IR-SE and NMR T 1 at reference T 1 ¼ 50 ms (scanners 2-9) and T 1 ¼ 500 ms (scanners 1 and 10), with these values outside the limits of agreement. The deviation at 500 ms is caused by underperformance of fit (Supporting Information Eq.
[1]) in some data sets (scanners 1, 6, 8, and 10) (Supporting Fig. S1 ). When used without lower and upper bounds for the parameters, the fit performs better in some cases (Supporting Fig. S1 ), but in other cases returns nonphysical fitted parameters (e.g., negative noise, 1-cos (Inversion Angle) > 2). Because of these deviations, only the NMR measurements were used as the reference standard for the calculation of accuracy.
Accuracy Assessment

Common IR-SE Protocol
The results of the accuracy assessment of the common IR-SE protocol are displayed in Table 3 and Figure 3 . For the full range of reference T 1 values of the phantom solutions (20- 2000 ms) , the range of median accuracy error among the 10 platforms (Table 3) Table S4 . Among the factors tested separately in a general linear mixed model, the sample (solution), or the actual T 1 value, was identified as a significant (P < 10 À6 ) independent predictor of accuracy (Fig. 3) for T 1 measurements with the common IR-SE protocol. T 1 measurements were significantly less accurate for solution sample S12 (reference T 1 $45 ms) than for all other samples ( Fig. 3 ; adjusted P < 10 À6 ).
Common VFA Protocol
For the full range of reference T 1 values of the phantom solutions (20-2000 ms), the range of median accuracy error among the 10 platforms ( Table  S4 . Field strength was identified as a significant (P ¼ 0.006) independent predictor (Fig. 3) , and scanner (Fig 3; P ¼ 0.0003) as a significant predictor of accuracy of T 1 measurements with the common VFA protocol. T 1 measurements with the common VFA protocol were overall less accurate (adjusted P ¼ 0.006) at 3 T than at 1.5 T (Fig. 3) . However, of the eight 3T scanners, seven scanners did not reach a statistically different accuracy error than the two 1.5T scanners (Fig. 3) . Significant differences in accuracy of the common VFA protocol among scanners are summarized in the Supporting Information.
Site-Specific Protocols
The results of the accuracy assessment of the site-specific protocols are shown in Figure 4 . Accuracy errors ranged between 3.2 and 37.2% for the site-specific protocols. The VTR protocol 1 for the prostate, Look-Locker protocol 4a for the liver, VFA protocol 4b for the liver, VFA protocol 9b for the liver, and VFA 9c and 9d for the prostate had accuracy errors of less than 15%. Protocol (P ¼ 0.002) and scanner (P ¼ 0.0014) were identified as significant predictors of accuracy of T 1 measurements with the site-specific protocols. The stepwise model-selection procedure identified no independent predictors of accuracy.
The VTR protocol 1 for the prostate was significantly more accurate (adjusted P ¼ 0.03) than protocol 2 (VFA for brain at 3 T with six flip angles; Supporting Table  S2 ). Among VFA protocols (2, 3, 4b, 4c, 8, 9b, 9c, 9d ; Supporting Tables S1 and S2), protocols 9c and 9d for the prostate (VFA with two flip angles at 1.5 T; Supporting Table S2 ) were significantly (adjusted P ¼ 0.03) more accurate than protocol 2.
Test-Retest Repeatability Assessment
Common IR-SE Protocol
The median precision error range across scanners was 0.2 to 8.3% for the full range of reference T 1 values in the phantom (Table 3 ). The distributions of precision errors for ranges of low, intermediate, and high reference T 1 values are summarized in Supporting Table S5 . Among the factors tested, scanner was identified as a significant (P < 10 À6 ) independent predictor of test-retest repeatability for T 1 measurements with the IR-SE common protocol (Fig. 5) . The IR-SE T 1 measurements were significantly less repeatable on scanner 7 than on all of the other scanners ( Fig. 5 ; adjusted P < 10 À6 ).
Common VFA Protocol
The median precision error range across scanners was 0.7 to 25.8% for the full range of reference T 1 values in the phantom solutions (Table 3 ). The distributions of precision errors for ranges of low, intermediate, and high reference T 1 values are summarized in Supporting Table  S5 . Field (P < 0.0001), scanner (P < 10 À6 ), and vendor (P ¼ 0.0012) were identified as significant predictors of test-retest repeatability of T 1 measurements with the common VFA protocol, when tested separately in a general linear mixed model. The model-selection procedure identified scanner as the independent predictor of testretest repeatability (Fig. 5) . Among the variable subsets not containing scanner, field was the independent predictor of test-retest repeatability. In subsets excluding scanner or field, vendor was the independent predictor of test-retest repeatability. Overall, T 1 measurements were less repeatable at 3 T than at 1.5 T (adjusted P < 0.0001) (Fig. 5) . Similar to the accuracy results, five of the eight 3T scanners had substantially worse performance for repeatability of measurements than the two 1.5T scanners ( Fig. 5 ; see also Supporting Information).
Site-Specific Protocols
The results of repeatability assessment of the site-specific protocols are shown in Figure 4 . Precision errors ranged between 0.25 and 40% for the site-specific protocols. LookLocker protocols 4a and 9a for the liver, VFA protocols 2 and 3 for the brain, VFA protocol 8 for the breast, VFA protocol 9b for the liver, and VTR protocol 6 for the brain had precision errors of less than 15%. Complete statistical comparison results for the repeatability of site-specific protocols are provided in the Supporting Information. Protocol (P < 0.0001), scanner (P ¼ 0.0001), vendor (P ¼ 0.0001), and method (P ¼ 0.035) were identified as significant predictors of test-retest repeatability of T 1 measurements with the site-specific protocols, when tested separately in a general linear-mixed model. The model-selection procedure identified protocol as an independent predictor of repeatability.
FIG. 3.
Accuracy errors of the IR-SE and VFA common protocols for each solution sample with reference T 1 value (top), field strength (middle), and scanner (bottom), using NMR measurement as the reference. The accuracy errors were calculated for the T 1 measurements in the test scanning session, using NMR measurements as the reference. Bar graphs represent general linear model least square means 6 standard error. Smaller numbers represent better accuracy. Sample was the significant (P < 10
À6
) independent predictor of accuracy of IR-SE T 1 measurements; field was the significant (P ¼ 0.006) independent predictor; and scanner was a significant (P ¼ 0.0003) predictor of accuracy of T 1 measurements with the VFA common protocol. Scanner was the significant, independent predictor of precision error of T 1 measurements with the common IR-SE protocol (P < 10 À6 ) and the common VFA protocol (P < 10
).
Protocols with more prescribed flip angles (protocols 2 and 3 for the brain at 3 T with six and seven flip angles, and protocol 8 for the breast at 3 T with 10 flip angles) had significantly better test-retest repeatability than VFA protocols with two or three flip angles (protocol 4b for the liver, 9c and 9d for the prostate; adjusted P < 10 À4 ). The VFA protocols for the same anatomical application were more repeatable at 1.5 T than at 3 T (e.g., liver protocol 9b at 1.5 T was more repeatable than liver protocol 4b at 3 T ( adjusted P < 10 À4 ), and prostate protocol 9c at 1.5 T was more repeatable than prostate protocol 4c at 3 T (adjusted P ¼ 0.0022)), with one exception: Breast protocol 8 at 3 T was more repeatable than breast protocol 10 at 1.5 T (adjusted P < 10 À4 ). Unlike the VFA approach, the Look-Locker IR method did not show significantly different repeatability between protocols at different field strengths (e.g., protocols 4a and 9a for the liver did not have significantly different repeatability). Look-Locker IR protocols 4a (at 3 T) and 9a (at 1.5 T) for the liver were significantly (adjusted P < 10 À4 ) more repeatable than the VFA protocol 4b for the liver at 3 T. The superior repeatability of Look-Locker IR protocols versus VFA is also apparent from the comparison of precision errors between the methods. LookLocker IR had significantly higher test-retest repeatability (precision error: 0.68 6 4.64%) than VFA (precision error: 14.7 6 2.04%, P ¼ 0.038) and PD (precision error: 19.8 6 5.49%, P ¼ 0.049), and borderline significantly higher repeatability than VTR (15.98 6 4.34%, P ¼ 0.088). There were no significant differences in repeatability among the other methods (P range 0.8-0.99).
Interplatform Reproducibility
Excellent agreement was found in T 1 measurements between platforms, for both the IR-SE (1.5 T: ICC ¼ 0.997, P < 10 À6 ; 3 T: ICC ¼ 0.999, P < 10 À6 ) and VFA (1.5 T: ICC ¼ 0.993, P < 10 À6 ; 3 T: ICC ¼ 0.947, P < 10 À6 ) common protocols. Interplatform CVs of common IR-SE and VFA T 1 values for 1.5 T (two scanners) and 3 T (eight scanners) are displayed in Table 4 and Figure 6 . Interplatform reproducibility was higher at 1.5 T (root mean square (RMS) CV 11.13%, range: 0.1-18.8%) than at 3 T (RMS CV 22.87%, range: 16.6-45.5%) for the common VFA protocol (P ¼ 0.004; Table 4 ). For the common IR-SE protocol, there was no significant difference in reproducibility at different field strengths (1.5 T: RMS CV 8.21%, range: 0.11-23%; 3 T: RMS CV 5.46%, range 0.99-14.6%; P ¼ 0.379) ( Table 4 and Fig. 6 ). As expected, at both field strengths the overall reproducibility was higher for the common IR-SE protocol (P ¼ 0.028) than for the common VFA protocol (P ¼ 0.001). Interplatform CV was less than 10% for the IR-SE sequence for most phantom samples, with the exception of samples with reference NMR T 1 s of 33, 45, and 500 ms (Fig. 6 ).
DISCUSSION AND CONCLUSIONS
Accurate, repeatable, and reproducible quantification of baseline-tissue T 1 is highly desired for patient-specific, FIG. 6 . Interplatform CVs at 1.5 T (top) and 3 T (bottom) for each sample with known NMR T 1 . Interplatform CV was less than 10% for the IR-SE sequence for all phantom samples, with the exception of the ones with reference NMR T 1 values of 33 ms at 1.5 T, 45 ms at 3 T, and approximately 500 ms at both field strengths, as a result of fit underperformance at these values. robust perfusion quantification from DCE-MRI studies. The present study expands the scope of previous multicenter studies of the variability of quantitative MR relaxometry metrics (31, 32, 46) . In addition to investigating sources of error with the same T 1 mapping protocols across scanner platforms, our study also compared the performance of 14 site-specific T 1 mapping protocols used for different oncological applications. Our study performed a centralized analysis of site data, to control for sources of error such as the data-fitting method and software packages used for analysis. In particular, different results may have been obtained for the VFA protocols by fitting the VFA data with the linearized version of the signal equation, rather than the full signal equation. The knowledge gained on the magnitude of accuracy and repeatability errors, as well as of interplatform variability of T 1 measurements, obtained with different protocols potentially allows future studies on the propagation of T 1 measurement errors to pharmacokinetic parameters obtained from DCE-MRI studies. Our work showed the field strength and scanner dependence of accuracy and test-retest repeatability of T 1 measurements. We observed significantly lower interplatform reproducibility at 3 T compared with 1.5 T for the common VFA protocol, and significantly lower reproducibility of the common VFA protocol compared with the IR-SE protocol at both field strengths. Our study also confirmed the expected high accuracy, repeatability, and interplatform reproducibility of T 1 measurements with a common IR-SE protocol. However, because of the small number of 1.5T systems, the reproducibility findings for both common protocols would need to be validated with a larger 1.5T scanner pool. For site-specific T 1 quantification protocols for different DCE-MRI applications, accuracy and repeatability of measurements were influenced primarily by the type of protocol and by scanner. Our study identified several VFA and Look-Locker IR protocols that achieved clinically acceptable accuracy and repeatability errors of less than 15%.
We observed high concordance between IR-SE and the reference NMR T 1 values, with deviations from unity line at the solution samples with 500 ms and higher T 1 values (1500-2000 ms). Bland-Altman plots showed discrepancy between IR-SE and reference NMR T 1 values at low T 1 values ( < 50 ms) and 500 ms, but not at high T 1 values. Greater interplatform CV was also observed for the IR-SE sequence at 500 ms at both field strengths. The deviation from the reference standard in samples with high T 1 values can be explained by not fully recovered longitudinal magnetization (22, 46) at the relatively short TR (5000 ms) chosen for manageable scanning time. The variability of IR-SE T 1 measurements of the 500-ms sample is caused by underperformance of the fitting function with magnitude IR-SE signal data, which can be remedied in future studies by fitting complex signal data (22, 46) .
Our findings show that the common IR-SE protocol had the highest accuracy in the range of 60 to 2000 ms (accuracy error < 11%). Thus, for applications in which accuracy is important and longer acquisition times are possible without motion artifacts, an IR-SE protocol can be used as calibration for a faster T 1 measurement protocol (22) . Accuracy with the common IR-SE protocol was also shown to depend on the NiCl 2 solution T 1 , with lower accuracy for samples with very low reference T 1 (23-50 ms) . These samples also showed interplatform CV greater than 10%. Our implemented IR-SE protocol had up to two measurements with short inversion times (24-50ms), which makes it difficult to resolve low T 1 .
Inversion-recovery methods (IR-SE, Look-Locker modified IR) provided repeatable and reproducible T 1 measurement. Lower interplatform CV was observed for the common IR-SE protocol compared with the VFA common protocol. The IR-SE precision error was less than 5% for most platforms, and a significantly lower testretest precision error/higher repeatability was observed for the Look-Locker IR than for the VFA and PD methods in the comparison by general linear model. These results are in agreement with the work of Stikov et al (22) , which found greater stability of T 1 measurements in vitro and in white matter with Look-Locker IR than with VFA. Of note, the observed dependence of repeatability of the common IR-SE protocol on the scanner platform was likely driven by outlier test-retest precision errors at one of the scanners. This could be caused by periodic signal variation on the outlier scanner, as observed in other studies (46) . In our study, the Look-Locker IR protocol optimized for the liver did not have greater accuracy than VFA protocols for the liver, but had greater test-retest repeatability. Because superior repeatability with the Look-Locker IR method was observed on only two platforms (1.5 and 3 T) from the same vendor, this finding should be confirmed in a future multiplatform, multivendor study.
For T 1 measurements with the common VFA protocol, we observed field strength dependence of accuracy and scanner dependence of test-retest repeatability, as well as significantly higher interplatform variability at 3 T. The deviations from the reference NMR measurements seen with the common VFA and site-specific protocols (as high as 30-40%) cannot be attributed only to differences in temperature (accounting for less than 2% error in T 1 for the recorded temperature range (32)). These are likely caused by B 1 field inhomogeneity, which is more pronounced at 3 T compared with 1.5 T (8, 22) , and leads to variability in T 1 values among scanners, even for a common VFA protocol with the same prescribed flip angles. Vendor was also a significant predictor of repeatability of T 1 measurements with the common VFA protocol, which suggests differences in implementation across vendors. Although the participating sites did their best to implement a uniform VFA protocol, the B 1 pulse profiles were unknown and could vary among scanners and vendors and change across the range of flip angles (32) . Future implementation of a standardized VFA protocol would involve outreach to vendors to ensure that the B 1 correction methods used are appropriate for the pulse profiles used by the vendors in their implementations of VFA sequences. Accounting for incomplete spoiling of the spoiled gradient-echo signal and using the vendorspecific radiofrequency phase-difference increment can further be used to eliminate T Ã 2 bias in T 1 quantification (33). Our results with the common VFA protocol can help facilitate the effort of optimizing VFA protocols (47, 48) by identifying combinations of flip angles that minimize accuracy error with respect to the reference NMR-measured T 1 values.
Our study showed that although the VTR protocol and VFA protocols with fewer flip angles were more accurate (accuracy error < 5%) than a VFA protocol with multiple flip angles (e.g., VTR prostate protocol 1, and prostate VFA protocols 9c and 9d versus protocol 2 for the brain), these protocols were significantly less repeatable (precision errors of 20-40%). For clinical applications in which both accuracy and repeatability are important, we would recommend protocols with accuracy and repeatability errors of less than 15%, such as the Look-Locker protocol 4a for the liver, VFA protocol 9b for the liver, or VFA protocol 9d for the prostate at 1.5 T.
Our study had some limitations. First, we did not collect complex signal data for any of the T 1 mapping methods, to simulate the clinical setting, in which only magnitude data are typically collected. Second, we did not perform B 1 mapping to measure the applied flip angles for the VFA measurements. B 1 mapping methods (49) (50) (51) (52) (53) are usually time-consuming, not standardized among platforms and vendors, and may be specific absorption rate-prohibitive (51), which limits their clinical applicability. Furthermore, B 1 may not be accurately measured as a result of B 0 inhomogeneities and tissue conductivity (22, 54) . Third, because participation in the study was determined by voluntary response to a survey, the study design was not statistically balanced for field strength (two 1.5T scanners versus eight 3T scanners) and vendors (six Siemens scanners, two GE scanners, two Phillips scanners), which may explain why vendor was one of the significant predictors of repeatability, but not of accuracy. The number of site-specific protocols was also not balanced between sites. Fourth, the effects of small variations in phantom positioning away from isocenter were not studied.
In conclusion, our findings show that accuracy, repeatability, and interplatform reproducibility of T 1 measurements depend on the T 1 measurement sequence and protocol used, the field strength, and the range of reference T 1 values. Among the site-specific protocols tested, VFA protocols with two to three flip angles optimized for different applications achieved an acceptable balance of accuracy and repeatability in T 1 quantification (errors < 15%). The VFA protocols with two to three flip angles may be of interest to investigators designing translational DCE-MRI studies, as they have the advantage of higher spatial coverage achieved in the acquisition time of one breath-hold. Further optimization in terms of flipangle choice for each tissue application, and the use of B 1 correction standardized among vendors, is needed to improve the robustness of VFA protocols for T 1 mapping in DCE-MRI for the purpose of multicenter studies.
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